Abstract
About 4% of the world’s population has type 2 diabetes mellitus (T2DM), and the available hypoglycemic drugs for treating diabetes have some side effects. Therefore, research on the extraction of hypoglycemic components from plants has gradually become popular. This study aimed to investigate the hypoglycemic effects of polyphenol-rich Rosa roxburghii Tratt extract (RP) isolated from Rosa roxburghii Tratt fruit and of four constituents (IRP 1–4 ) isolated from RP on db/db mice. The results indicated that the oral administration of RP and IRP 1–4 could markedly decrease the food intake, water intake, fasting blood glucose (FBG), and serum insulin levels in the db/db mice. Glucose intolerance, insulin resistance, and oxidative stress were ameliorated in the RP and IRP 1–4 groups. Histopathological observation revealed that RP and IRP 1–4 could effectively protect the liver fat against damage and dysfunction. RP and IRP 1–4 also increased the hepatic and muscle glycogen contents by increasing the phosphorylation and reducing the expression of glycogen synthase kinase 3β (GSK3β). The activities of glucokinase (GCK), phosphoenolpyruvate carboxylase (PEPCK), and glucose-6-phosphatase (G6PC) and their respective mRNA expression levels in the liver of db/db mice were simultaneously increased and decreased in the intervention groups. RP and IRP 1–4 significantly increased the expression of phosphatidylinositol 3-kinase (P13K) and the phosphorylation of protein kinase B (AKT). These results indicate that RP and IRP 1–4 exhibit good hypoglycemic effects by activating the P13K/AKT signaling pathway and regulating the expression of FOXO1 and p-GSK3β proteins, controlling hepatic gluconeogenesis and improving hepatic glycogen storage insulin resistance. Therefore, RP and IRP 1–4 could be utilized as the hypoglycemic functional component to alleviate the symptoms of T2DM.
Highlights
Type 2 diabetes mellitus (T2DM) is a systemic metabolic disorder disease
High-performance liquid chromatography coupled with mass spectrometry revealed that IRP-1 produced a molecular ion peak with [M-H] of 951
We studied the effects of RP and IRP 1–4 on glucose metabolism and identified the underlying mechanism using db/db mice
Summary
Type 2 diabetes mellitus (T2DM) is a systemic metabolic disorder disease. Currently, approximately 4% of the global population lives with diabetes, and it is a worldwide problem. T2DM is triggered by insulin resistance (IR), caused by decreased glucose uptake and insulin sensitivity due to obesity, ageing, and sedentary lifestyle [2]. Decreased GCK activity and increased G6PC and PEPCK activities are the leading causes of T2DM [3]. The phosphatidylinositol 3-kinase/protein kinase B (P13K/AKT) pathway is one of the major insulin signaling pathways focused on in the current research; the abnormal expression of factors associated with this pathway are some of the primary causes of T2DM. Some hypoglycemic drugs, such as metformin and repaglinide, can cause nausea and vomiting. The side effects of these drugs can be reduced, and natural plant-derived hypoglycemic ingredients can increase their safety as an adjunct to drug therapy [4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
